Lumenaussehender Stent zur Verabreichung einer Gezielten Therapie
Anmelder: Boston Scientific Scimed, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4736820
- Anmeldetag
- 18. Mai 2022
- Veröffentlichung
- 6. Mai 2026
- Rechtsraum
- EP
- IPC
- A61F2/966
Abstract
A system for delivering a functional and/or therapeutic agent may comprise a stent comprising a lumen extending longitudinally therethrough being configured to shift between a first configuration and a second configuration and a functional and/or therapeutic agent. When in the second configuration, the stent may define a first retention member, a second retention member, and a saddle region extending therebetween. When the stent is positioned within a body lumen, the first retention member, the second retention member, the saddle region and a portion of a tissue wall of the body lumen may define a volume which is configured to retain the functional and/or therapeutic agent therein.
Anmelder
- Firma
- Boston Scientific Scimed, Inc.
- Land
- 🇺🇸 USA
US-amerikanische Tochtergesellschaft von Boston Scientific. Das Unternehmen entwickelt medizinische Geräte für minimalinvasive Diagnostik und Therapie, unter anderem in Kardiologie und Endoskopie.
3.520 Patente in unserer Datenbank